Although we found such alternative fusion transcripts in supratentorial NRNY ependymoma, we did not detect the previously published ones: FOXO1-STK24 [5], MAML2-ASCL2, or MARK2-ADCY3 [16]. This evidence concerns the gene MARK2 and ependymoma.